3SBio Inc. (OTCMKTS:TRSBF) Short Interest Up 38.7% in July

3SBio Inc. (OTCMKTS:TRSBF) saw a large increase in short interest in July. As of July 15th, there was short interest totalling 587,600 shares, an increase of 38.7% from the June 30th total of 423,800 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

3SBio Stock Performance

TRSBF stock remained flat at $0.77 on Friday. The firm has a 50 day moving average of $0.78 and a 200 day moving average of $0.79. 3SBio has a 12 month low of $0.77 and a 12 month high of $0.77.

3SBio Company Profile

3SBio Inc, an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer; TNF, pre-filled aqueous injection solution.